Introduction Interest on the impact of variant histology in bladder cancer prognosis is increasing. Although squamous differentiation is the most well characterized, only recently have less common variants gained increased recognition. We assessed whether squamous differentiation conferred a worse prognosis than nonvariant urothelial bladder cancer in a contemporary cohort of patients treated with radical cystectomy given the increased awareness of other less common variants. Methods We identified patients with squamous differentiation or nonvariant histology on transurethral resection of bladder tumor and/or cystectomy pathology during a 10-year period. Disease specific and overall survival were evaluated using Kaplan-Meier method...
Background and Objectives: To evaluate the oncological impact of squamous cell carcinoma (SCC) varia...
To evaluate the concordance and prognostic role of histologic variants of bladder urothelial carcino...
Over 90% of bladder tumours are urothelial (transitional cell) carcinomas; most of the remainder are...
Objectives To assess the effect of non-squamous differentiation (non-SQD) variant histology on surv...
Objective: To evaluate the effect of variant histology on pathological and survival findings in pati...
INTRODUCTION AND OBJECTIVES: Bladder cancer (BCa), may present with variant morphologic features tha...
Abstract Background The independent prognostic role of squamous differentiation in pT1 bladder uroth...
INTRODUCTION: Knowledge of the comparative oncologic outcomes of histologic variants after radical c...
CONTEXT: Variant histology of muscle-invasive (MIBC) and metastatic (mBC) bladder cancer may define ...
Purpose: It is well established that muscle-invasive urothelial carcinoma (UC) has a marked propensi...
Background: It is controversial if urothelial carcinoma of the bladder with squamous and/or glandula...
To investigate the prognostic significance of squamous and/or glandular differentiation in urothelia...
Abstract OBJECTIVE: To evaluate the concordance and prognostic role of histologic variants of blad...
Within the Surveillance, Epidemiology, and End Results database, we evaluated cancer-specific mortal...
BACKGROUND: Neoadjuvant chemotherapy in pure urothelial bladder cancer provides a significant surviv...
Background and Objectives: To evaluate the oncological impact of squamous cell carcinoma (SCC) varia...
To evaluate the concordance and prognostic role of histologic variants of bladder urothelial carcino...
Over 90% of bladder tumours are urothelial (transitional cell) carcinomas; most of the remainder are...
Objectives To assess the effect of non-squamous differentiation (non-SQD) variant histology on surv...
Objective: To evaluate the effect of variant histology on pathological and survival findings in pati...
INTRODUCTION AND OBJECTIVES: Bladder cancer (BCa), may present with variant morphologic features tha...
Abstract Background The independent prognostic role of squamous differentiation in pT1 bladder uroth...
INTRODUCTION: Knowledge of the comparative oncologic outcomes of histologic variants after radical c...
CONTEXT: Variant histology of muscle-invasive (MIBC) and metastatic (mBC) bladder cancer may define ...
Purpose: It is well established that muscle-invasive urothelial carcinoma (UC) has a marked propensi...
Background: It is controversial if urothelial carcinoma of the bladder with squamous and/or glandula...
To investigate the prognostic significance of squamous and/or glandular differentiation in urothelia...
Abstract OBJECTIVE: To evaluate the concordance and prognostic role of histologic variants of blad...
Within the Surveillance, Epidemiology, and End Results database, we evaluated cancer-specific mortal...
BACKGROUND: Neoadjuvant chemotherapy in pure urothelial bladder cancer provides a significant surviv...
Background and Objectives: To evaluate the oncological impact of squamous cell carcinoma (SCC) varia...
To evaluate the concordance and prognostic role of histologic variants of bladder urothelial carcino...
Over 90% of bladder tumours are urothelial (transitional cell) carcinomas; most of the remainder are...